How to use the speech recognition tool?
NCT03847272
USTEKINISU
A multicenter phase 2 single-arm proof-of-concept trial assessing the efficacy and safety of ustekinumab in association with prednisone, for the treatment of non-infectious severe uveitis (NISU)
Type: Interventional
Status of the trial: Active, Recruiting
Orphan Drug Recognition: Yes
Inclusion
- Opening Date: 2019-08-01
- Closing Date: 2022-01-01
Criteria
Children: No
Adults: Yes
Funder Type: public
HCP: Principal investigators
HCP: Other investigators
Within ERN-EYE members
Principal investigators
Other investigators
Workgroups
Anterior Segment Rare Eye Diseases (WG4)